Rational optimization of a human neutralizing antibody of SARS-CoV-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rational optimization of a human neutralizing antibody of SARS-CoV-2

Published:2021-08 Issue: Volume:135 Page:104550
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Chen Jiao,Wu Fei,Lin Dan,Kong Weikang,Cai Xueting,Yang Jie,Sun Xiaoyan,Cao Peng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference62 articles.

1. Novel coronavirus: where we are and what we know;Cheng;Infection,2019

2. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

4. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention;Wu;J. Am. Med. Assoc.,2020

5. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes;Zhang;Emerg. Microb. Infect.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody drugs targeting SARS-CoV-2: Time for a rethink?;Biomedicine & Pharmacotherapy;2024-07

2. Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants;Viruses;2024-06-01

3. Structure-Based Optimization of One Neutralizing Antibody against SARS-CoV-2 Variants Bearing the L452R Mutation;Viruses;2024-04-05

4. Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor;Scientific Reports;2023-09-19

5. Bioinformatic Screening of Compounds from Iranian Lamiaceae Family Members against SARS-CoV-2 Spike Protein;Letters in Drug Design & Discovery;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3